InvestorsHub Logo
Followers 8
Posts 450
Boards Moderated 0
Alias Born 10/04/2010

Re: staccani post# 2766

Tuesday, 02/07/2017 1:18:44 PM

Tuesday, February 07, 2017 1:18:44 PM

Post# of 3836
I would agree with that and Dr. Redmond is the chair of the session so is well respected.

It just amazes me how wrong Traber has been in everything he's done, he announced in 2010 that they had completed a plan, with FDA approval, for a Phase 2 cancer trial and then walked away from it. Had they proceeded with funding that could have been easily been obtained in the 2012-2013 time frame when the stock was trading in the $5-$10 range things could have been much different.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News